Malignant Melanoma Clinical Trials

A listing of Malignant Melanoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35294

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Arizona

Phoenix Arizona 85016

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

California

NEW

Research Center
Los Angeles California

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

NEW

Research Center
Sacramento California

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

NEW

Research Center
San Diego California

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

View More ▼

Los Angeles California 90027

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Los Angeles California 90025

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Los Angeles California 90095

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Los Angeles California 90025

Patients are needed to participate in a clinical research study evaluating IMCgp100, durvalumab and tremelimumab for the treatment of Malignant Melanoma, Cutaneous Melanoma

Los Angeles California 90025

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Los Angeles California 90024

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Orange California 92868

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Orange California 92868

A clinical trial seeking patients for a research study for the treatment of Melanoma or Malignant Melanoma

Roseville California 95661

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Santa Clara California 95051

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

South San Francisco California 94080

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Stanford California 94305

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Vallejo California 94589

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Colorado

NEW

Research Center
Aurora Colorado

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

View More ▼

Aurora Colorado 80045

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Aurora Colorado 80045

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Aurora Colorado 80045

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Connecticut

NEW

Research Center
Farmington Connecticut

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

NEW

Research Center
Farmington Connecticut

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

NEW

Research Center
New Haven Connecticut

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

Florida

Fort Myers Florida 33901

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Sarasota Florida 34232

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Tampa Florida 33612

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

West Palm Beach Florida 33401

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Illinois

NEW

Research Center
Chicago Illinois

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

View More ▼

Park Ridge Illinois 60068

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Indiana

Indianapolis Indiana 46202

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Iowa

Iowa City Iowa 52242

A clinical research study of CMP-001 and Pembrolizumab for the treatment of Stage IV Skin Melanoma

Massachusetts

Boston Massachusetts 02215

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Michigan

NEW

Research Center
Ann Arbor Michigan

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

Minnesota

Rochester Minnesota 55905

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Missouri

Kansas City Missouri 64111

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Kansas City Missouri 64131

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

St. Louis Missouri 63110

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

St. Louis Missouri 63130

Patients are needed to participate in a clinical research study evaluating IMCgp100, durvalumab and tremelimumab for the treatment of Malignant Melanoma, Cutaneous Melanoma

New Jersey

NEW

Research Center
Hackensack New Jersey

A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037)

View More ▼

Randolph New Jersey 07869

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

New York

New York New York 10065

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

New York New York 10065

A clinical research study of TRX518 for the treatment of Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies

North Carolina

Durham North Carolina 27710

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Ohio

Cleveland Ohio 44195

A clinical research study of TRX518 for the treatment of Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies

Cleveland Ohio 44106

A clinical research study of TRX518 for the treatment of Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies